Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258336
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2005-11-22
Brief Title:
Rituximab Vaccine Therapy and GM-CSF in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
Favrille
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000449719
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Favrille
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None